This trial is testing whether adding surgery or radiation therapy to standard treatment for prostate cancer that has spread to other parts of the body lowers the chance of the cancer growing or spreading.
1 Primary · 3 Secondary · Reporting Duration: Up to 8 years
Active Control
Experimental Treatment
1273 Total Participants · 3 Treatment Groups
Primary Treatment: Quality-of-Life Assessment · No Placebo Group · Phase 3
Age 18+ · Male Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: